Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

Natural history of liver fibrosis progression in patients with chronic hepatitis C

Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c

Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021

Liver fibrosis

Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958

A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C

Wai, C.-T., Greenson, J. K., Fontana, R. J., Kalbfleisch, J. D., Marrero, J. A., Conjeevaram, H. S., & Lok, A. S.-F. (2003) · Hepatology · doi:10.1053/jhep.2003.50346 · Cited by 4,406

Liver cirrhosis

Schuppan, D., & Afdhal, N. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60383-9 · Cited by 2,089

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.006 · Cited by 1,875

Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC

Corpechot, C., El Naggar, A., Poujol-Robert, A., Ziol, M., Wendum, D., Chazouillères, O., de Lédinghen, V., Dhumeaux, D., Marcellin, P., Beaugrand, M., et al. (2006) · Hepatology · doi:10.1002/hep.21151 · Cited by 441

Hepatic fibrosis: molecular mechanisms and drug targets

Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., & Mallat, A. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095906 · Cited by 325

ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis

Daniels, S. J., Leeming, D. J., Eslam, M., Hashem, A. M., Nielsen, M. J., Krag, A., Karsdal, M. A., Grove, J. I., Neil Guha, I., Kawaguchi, T., et al. (2019) · Hepatology · doi:10.1002/hep.30163 · Cited by 273

Ability of noninvasive scoring systems to identify individuals in the population at risk for severe liver disease

Hagström, H., Talbäck, M., Andreasson, A., Walldius, G., & Hammar, N. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.09.008 · Cited by 182

The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort

Okamura, T., Tanaka, H., Miyamatsu, N., Hayakawa, T., Kadowaki, T., Kita, Y., Nakamura, Y., Okayama, A., & Ueshima, H. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.01.024 · Cited by 172

A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores

De Vincentis, A., Tavaglione, F., Jamialahmadi, O., Picardi, A., Antonelli Incalzi, R., Valenti, L., Romeo, S., & Vespasiani-Gentilucci, U. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.05.056 · Cited by 158

Serum wisteria floribunda agglutinin-positive Mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis

Umemura, T., Joshita, S., Sekiguchi, T., Usami, Y., Shibata, S., Kimura, T., Komatsu, M., Matsumoto, A., Ota, M., & Tanaka, E. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.118 · Cited by 127

Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis

Floreani, A., Cazzagon, N., Martines, D., Cavalletto, L., Baldo, V., & Chemello, L. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.06.011 · Cited by 68

Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus‐positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus

Tanaka, H., Tsukuma, H., Yamano, H., Oshima, A., & Shibata, H. (2004) · International Journal of Cancer · doi:10.1002/ijc.20507 · Cited by 57

Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLD

Charu, V., Liang, J. W., Mannalithara, A., Kwong, A., Tian, L., & Kim, W. R. (2024) · Hepatology · doi:10.1097/hep.0000000000000908 · Cited by 35

Role of Liver Biopsy in the Era of Direct-Acting Antivirals

Gonzalez, H. C., Jafri, S. M., & Gordon, S. C. (2013) · Current Gastroenterology Reports · doi:10.1007/s11894-012-0307-z · Cited by 25

Comparison of different liver fibrosis scores following sleeve gastrectomy

Alexander, H., Falk, R., Utz, S., Felix, D., Aladdin, A. D., Hermann, K., Laura, S., Johanna, B., & Michael, A. (2025) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-024-03569-5 · Cited by 8